abstract |
The present invention is effective for a substance that suppresses ENAH expression or function, specifically, an antisense nucleic acid, a ribozyme nucleic acid, a nucleic acid having RNAi activity, or an antibody that binds to ENAH, etc. against a transcription product of a gene encoding ENAH. An anti-tumor agent, specifically an angiogenesis inhibitor, which is contained as a component; and an angiogenesis inhibitor characterized by selecting an ENAH-encoding gene or a compound that reduces ENAH expression or ENAH function A screening method is provided. |